Bridging the Gap: Index Volume [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

128 Nairobi * natural

12th World AIDS Conference

SKeyword

Abstract

-Keyword

Abstract
wo selected hospitals in /Emerging psycho-social needs fo
ith HIV/AIDS in three slums, in Kenya/Peer support for y
e among sex workers in /Long-term impact of community p
mothers in the Slums of /What will happen to my children?
ational Hospital (KNH),, Kenya, from 1988/89 through 199
ational Hospital (KNH),, Kenya in 1997/Costs of care for H
patients and clients in a hospital/The effects of HIV/AIDS t
on the spread of HIV in: Evaluation with the model STDSI
Sexual practices among university freshmen/Sexual practi
men in Kayole slums of through IGA group processes/Em
ur for single mothers in urban and peri-urban slums/Prom
bination therapy versus NAIV children with HIV/AIDS in Romania/
viral therapy (HAART)/ Naive T cell subsets during acute infection
Issues of Italian Cohort Antiretroviral (ICONA) study and enr
T inhibitors among drug naive HIV-positive blood donors in Sao Pa
o protease inhibitors in patients at the time of primary infecti
1 infected antiretroviral subjects with CD4+ counts >400 cell
nhibitors (PI) in therapy patients/Activity of abacavir (1592,
V infected antiretroviral patients/Saquinavir/ritonavir may h
3TC + IDV in treatment HIV-infected patients (START 1)/An
3TC + IDV in treatment HIV-infected patients (START II)/An
TC/ZDV in antiretroviral subjects/Safety and activity of abac
eatment of antiretroviral, HIV-infected adults/Hydroxyurea in

33281
33284
33515
48*/34187
68*/42434
42446
42467
43490
60079
60157
60456
12263
12190
60929
11168
12201
286*/12204
12210
126*/12221
12223
12225
127*/12230
287*/12235

n antiretroviral therapy Thai adult population with CD4 count 12241
s sequential therapy in advanced HIV patients: The MASTE 12243
)/Dynamic changes in and activated T cells in blood and ly 269*/21112
-regulation of TNF-a in patients treated with potent anti-HIV 21180
T) increases circulating CD8+ T cell counts/Highly active ant 22345
udine (d4T) in therapy HIV-infected patients/A phase II ran 22371
plasma and PBMCs in patients with CD4+ T cells counts fro 22383
ntiretroviral therapy or nucleoside analogue experienced 22386
n protease inhibitor (PI) and pretreated HIV-infected patients 22390
patterns in HIV-infected patients receiving a four-drug combi 32304
rofile in a group of drug patients in Argentina/First study on r 41227
rvals over 12 months in and antiretroviral experienced HIV+ 509*/42260
d) in adult HIV(+)/AIDS patients/CD4 marker of immune rest 60235
n antiretroviral (ARV)- patients with CD4 counts of 20-300/ 60397
nevirapine in treatment and experienced patients/Combinat 60701
ntiretrovirals therapies naives /Patient perspective of clinical dise 12452
workers (ACWs) of the Nakalembe community in Masaka District 33262
/How do the PWAs and NAP + leaders behave, and why?/How do t 33483
on in Malawi/The role of NAPHAM support organization in Malawi/ 34275
c, dramas, role plays by /AIDS outreach education target 42251
r of persons addicted to narcotics /Sexual behavior of persons add 23242
y virus (HIV) activity, of NARL-1, an polycassine extracted from a k 41207
ive evaluation between NASBA and other commercial assays/Pla 42175
mparative evaluation of and Quantiplex HIV RNA assays f 42177
ic viral load of HIV-1 by technology in 32 laboratories locat 43463
NA levels/The use of for monitoring plasma HIV-1 RNA I 60306
/Usefulness of the new ultrasensitive assay (Nuclisens) fo 60679
st employers' initiative ( NAT EI)/The National AIDS Trust employe 44171
sex workers in Kwazulu Natal, South Africa/Acceptability of a vagi 33151
ex workers in Kwazulu midlands, South Africa/Prevalence 60860
n Spain: Data from the National Registry up to December 1997/H 11207
anada 1985-1996/The Perinatal HIV Surveillance Progr 13221
5-1996/HIV in Canada: HIV Test Surveillance data, 1985 13228
n Spain: Data from the Registry up to December 1997/H 13300
experience/The role of Commissions for UNESCO in an 13518
e to the HIV population/ attitudes and antifungal utilizatio 22222
e affected by HIV/AIDS/ front of people affected by HIV/AI 24138
S epidemic in Thailand/ AIDS hotline (non-charged) and t 24337
Condom Bank" on the Highway/Experience of "Condo 33102
rs and CSWS along the Highway 7 at Hosur, Tamilnadu/l 33107
axis hotline (PEPLine)/ clinicians' post-exposure prophyl 33185
ons learned at the CDC AIDS Hotline/A decade of educat 33295
167-861061/The Italian AIDS Help-Line 167-861061/Th 33299
try where silence rules/ awareness campaign in a countr 103*/34217
s of PWAs in Germany/ seminars of PWAs in Germany/ 34281
directly affected by HIV/ programme of treatment worksho 42230
f HIV/AIDS in Kenyatta Hospital (KNH), Nairobi, Kenya, f 68*/42434
ult patients in Kenyatta Hospital (KNH), Nairobi, Kenya in 42446
dical wards in Kenyatta Hospital between May 1996 and 42455
ampaign in Lithuania/ "STOP AIDS '97" campaign in Lit 43204
nd points/The Scottish AIDS/HIV Register - A complete 43419
nalysis of data from the HIV Sentinel Surveillance Syste 521*/43508
I prioritization process: experience in USA, 1993-1996/ 43510
Ith policy for HIV/STDs/ public health policy for HIV/STDs 43562
ol of HIV/AIDS in India/ policy for prevention and control 44118
' initiative (NAT EI)/The AIDS Trust employers' initiative ( 44171
t organizations and the AIDS Program in Myanmar/Part 44252

of women and HIV: The Community Advisory Board of th 44264
of women and HIV: The Community Advisory Board of th 44278
communities along the Highway, migration of menfolk to 60082
cing HIV+ donors at the Blood Transfusion Center (NBTC 60220
est: Data from the US Health Interview Survey/Rates of 60354
s, and members of the Coordinating Committee of Peopl 60760
s' perspective"/French national study "Life with treatments from t 12450
DS in India - Need for a STD surveillance system/HIV/AI 13292
Costa Rica, 1997/CAP AIDS survey in Costa Rica, 1997/ 23435
risk reduction among a sample of drug using women: The 23454
es in 1997: Results of a survey/The prevalence of HIV an 23510
n Africa: Evidence from surveys and censuses/The impa 24189
an experience from the community of women living with H 24284
Iling for drugusers" on a level/Training "test-counselling f 24327
hange in HIV+ men in a clinical trial/Change in loglo HIV 32180
e women - Data from a (US) survey of reproductive age 33106
desh/Development of guidelines of STD case manage 33251
exchange in the UK? A survey/What is the current state 33392
f condom efficacy in US samples: Trends, predictors, and 33427
ent tools for steering the HIV-prevention campaign in Ger 259*/33443
nt collaboration with an NGO for handicapped people/ST 33462
V positive women in the community of women living with H 33598
s: A comparison of two surveys/HIV/AIDS preventive atti 642*/34107
t between a NGO and a newspaper: A successful experie 586*/34219
DS: The experience of a network/Working with children wi 34235
V/Sol En Si's children's conference on HIV/Sol En Si's ch 34308
of PHA the challenge of networks/Legal service provision 34358
S/Perspectives plus: A network of psychologists working 34367
uture/Looking ahead: A advocacy coalition explores its fut 34378
esource allocation in a HIV care program - The US Ryan 34380
troviral therapy use in a study of HIV+ women/Predictors 42311
k of HIV infection in US samples: Trends, predictors, and 43122
actice in UK and Eire/A survey of antenatal HIV screenin 43136
erience/Establishing a blood transfusion service the Za 43217
cies/Interface between and international AIDS policies/I 43222
gn among truckers on a highway/Needs assessment desi 43346
Ds, and TB: Results of a study/Public health/corrections c 43405
rmance standards for a HIV prevention program/Setting 356*/43500
STDs in Tanzania/The strategic planning process for HI 43504
nt and development of and regional minority organizatio 43513
veillance/Developing a framework of HIV/AIDS surveillan 43521
ommitment: Adopting a AIDS policy framework in Kenya/ 43570
hallenges of developing legal frameworks in response to 44120
d States: Results from a telephone survey/AIDS stigma a 416*/44173
atterns and trends of and international financing of the r 647*/44232
h/Cost effectiveness of investment for prevention of HIV: 44246
th: Renewing Canada's AIDS strategy/Politics and health 44270
4-1996)/The Brazilian strategy for community action in S 44297
y in India/Evaluation of AIDS control programme using pr 44317
n/NGO - Networking at level and strategy development fo 60101
ental evaluation to build capacity to respond to the HIV epi 60366
en and their families/A Canadian HIV healthline and regi 60669
pact of the profile of the AIDS program director on the efici 60750
ortunistic infections in a nationally representative sample (HCSUS 13238
-related symptoms in a representative sample of HIV+ 42213
/CHAPS: Developing a co-ordinated, research based H 43309: The role of the United Nations, non-government organizations a 44252
ers for under resourced nations using income generation program 34144
herapy available to all /One world, one hope: The cost of 444*/42283
shorter survival for first in Vancouver, Canada/Dual epide 42449
k, low prevalence Asian: Bangladesh, Pakistan, and Mong 43523
o invited HIV/AIDS? 1st family-based support model/Who 60376
or adherence program/ Nationwide protease inhibitor adherence 32327
ndromes/Developing a nationwide public service advertising on S 588*/33450
mulary/Development of HIV/AIDS herbal formulary/D 60381
ances/HIV education in native North American communities: Asse 13410
protein expressing the V1/V2 domain of gpl20/Potent neu 550*/21194
V infection in a cohort of Canadian injection drug users/Dete 23513
ation and prevention in community settings/"Reaching aro 43168
frican green monkeys/ Natural host resistance to SIV-induced Al 11217
se hemophilic patients/ protease mutations observed in HI 60444
culosis patients and the natural history of HIV and TB co-infection/ 13260
y/A cohort study of the history of undetectable HIV RNA in 22377
t of HIV infection on the history of anal human papillomavir 23114

ction among IDUs and history of HIV infection in Ruili, Chi 23244
infection's influence on course of chronic C hepatitis/Eval 32120
ase/The aetiology and history of neutropenia in HIV disea 32152
g female sex workers in settings in Yunnan, China/Promoti 184*/33332
mily members and other helpers to engage substance abus 33604
tant HIV-1 variants and polymorphism in protease coding r 41210